These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3554484)

  • 41. [Meniere's disease. The clinical effect of gentamicin treatment].
    Kjaer D; Pedersen CB
    Ugeskr Laeger; 2000 May; 162(19):2739-43. PubMed ID: 10827541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacological treatment of Menière's disease.
    Brookes GB
    Clin Otolaryngol Allied Sci; 1996 Feb; 21(1):3-11. PubMed ID: 8674219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New trends in the medical treatment of Ménière's disease].
    Piccoli A
    Ann Laringol Otol Rinol Faringol; 1966; 65(5):669-84. PubMed ID: 6014507
    [No Abstract]   [Full Text] [Related]  

  • 45. Indomethacin blocks acute audiologic effects of furosemide in Meniere's disease.
    Arenberg IK; Goodfriend TL
    Arch Otolaryngol; 1980 Jul; 106(7):383-6. PubMed ID: 6992754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy of Meniere's disease.
    Malcomson KG
    Proc R Soc Med; 1971 Aug; 64(8):856-7. PubMed ID: 5569328
    [No Abstract]   [Full Text] [Related]  

  • 47. Serum osmolality in patients with Meniére's disease.
    Angelborg C; Klockhoff I; Stahle J
    Acta Otolaryngol; 1973 Dec; 76(6):450-4. PubMed ID: 4773110
    [No Abstract]   [Full Text] [Related]  

  • 48. The clinical drug trial in Menière's disease with emphasis on the effect of betahistine SR.
    Schmidt JT; Huizing EH
    Acta Otolaryngol Suppl; 1992; 497():1-189. PubMed ID: 1496890
    [No Abstract]   [Full Text] [Related]  

  • 49. Old and new in Ménière disease.
    Torok N
    Laryngoscope; 1977 Nov; 87(11):1870-7. PubMed ID: 916781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The physiologic role of corticosteroids in Ménière's disease.
    Farhood Z; Lambert PR
    Am J Otolaryngol; 2016; 37(5):455-8. PubMed ID: 27221028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medical treatment of Menière disease (author's transl)].
    Schmidt CL
    Laryngol Rhinol Otol (Stuttg); 1977 May; 56(5):407-9. PubMed ID: 141553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Physiologic Role of Corticosteroids in Menière's Disease: An Update on Glucocorticoid-mediated Pathophysiology and Corticosteroid Inner Ear Distribution.
    Froehlich MH; Lambert PR
    Otol Neurotol; 2020 Feb; 41(2):271-276. PubMed ID: 31821251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Block of the inner ear by the Ristov method in cases of Meniere's disease and syndrome in our records].
    Kuźniar A
    Otolaryngol Pol; 1975; 29(4):349-52. PubMed ID: 1161299
    [No Abstract]   [Full Text] [Related]  

  • 54. Cochlear blood flow related to hyperosmotic solution.
    Larsen HC; Angelborg C; Hultcrantz E
    Arch Otorhinolaryngol; 1982; 234(2):145-50. PubMed ID: 6807272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the treatment of vascular insufficiencies of the labyrinth with thymoxamine.
    Gill NW
    J Laryngol Otol; 1968 Mar; 82(3):231-45. PubMed ID: 5640991
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of galactose and isosorbide on cochlear blood flow.
    Larsen HC; Angelborg C
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(2):99-102. PubMed ID: 3601377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procedures for restoring vestibular disorders.
    Walther LE
    GMS Curr Top Otorhinolaryngol Head Neck Surg; 2005; 4():Doc05. PubMed ID: 22073053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological treatment of Menière's disease. A review of common remedies with special emphasis on vasodilators, including hyperosmolar substances and hearing.
    Angelborg C
    Scand Audiol Suppl; 1986; 26():33-6. PubMed ID: 3554484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperosmotic solutions and hearing Meniere's disease.
    Angelborg C; Klockhoff I; Larsen HC; Stahle J
    Am J Otol; 1982 Jan; 3(3):200-2. PubMed ID: 6798878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The treatment of hearing loss in Meniere's disease.
    Grant IL; Welling DB
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1123-44. PubMed ID: 9386248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.